Several serum lipid metabolites are associated with relapse risk in pediatric-onset multiple sclerosis.
Akash VirupakshaiahDimitrios Christos LadakisBardia NourbakhshPavan BhargavaSonam DilwaliVinícius Andreoli SchoepsKamil BorkowskiJohn W NewmanEmmanuelle WaubantPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
This study supports the role of some lipid metabolites in pediatric MS relapses and disability.